论文部分内容阅读
目的:观察0.1%普拉洛芬滴眼液治疗急性变态反应性结膜炎的临床疗效。方法:选取56例(112眼)我院患有急性变态反应性结膜炎患者,随机分成对照组和观察组,对照组用用0.05%富马酸依美斯汀,观察组用0.05%富马酸依美斯汀联合0.1%普拉洛芬,每天3次外用,分别在治疗前和治疗过程中的第1周(7天)和第2周(14天)的时候对患者进行随访进行评估,评价有效率跟治愈率。结果:在第1周的时候观察组跟对照组的有效率分别是73.3%跟10.0%,在第2周的时候,观察组与对照组的有效率分别是46.7%和20%,2组总有效率均为100%,观察组跟对照组均为见明显的不良副作用。结论:对于急性变态反应性结膜炎的治疗,普拉洛芬能够有效的缓解症状,而且未见明显的副作用,临床证明是一种有效而安全的治疗药物。
Objective: To observe the clinical efficacy of 0.1% pranoprofen eye drops in the treatment of acute allergic conjunctivitis. Methods: 56 cases (112 eyes) of our hospital with acute allergic conjunctivitis were randomly divided into control group and observation group, the control group with 0.05% emametic acid fumarate, the observation group with 0.05% Fuma Emamectin plus 0.1% pranoprofen was administered topically 3 times daily for follow-up prior to and during the first and second week of treatment (7 days and 2 weeks) (14 days) , Evaluation of the effective rate and cure rate. Results: The effective rates of the observation group and the control group were 73.3% and 10.0% respectively at the first week, 46.7% and 20% respectively in the observation group and the control group at the second week, Efficacy was 100%, the observation group and the control group are see obvious adverse side effects. CONCLUSIONS: For the treatment of acute allergic conjunctivitis, pranoprofen can effectively relieve the symptoms without obvious side effects, which is clinically proven to be an effective and safe therapeutic drug.